Create a free account to see ACCE Scores
Sign up for free to unlock scores, score breakdowns, and stock analysis.
QSI
↓ PDF (Pro)Quantum-Si Incorporated Class A Common Stock
HealthcareMedical DevicesUnited StatesNASDAQ
$0.95
-2.02%today
MKT CAP
$221M
+14.5% · 1Y
Earnings History
+11.5%
+25.5%
+41.4%
+10.8%
Q2 '25
Q3 '25
Q4 '25
Q1 '26
Analyst Targets
Current price
$0.95
Low
$1.00
Analyst Mean
$2.50
High
$4.00
3 analystsBuy
Full Financials
Trailing P/E-
Forward P/E-
EV/EBITDA-0.8x
Price/Sales-
Dividend Yield-
Revenue Growth YoY-69.4%
Earnings Growth YoY-
Revenue Growth QoQ-42.8%
5y Revenue CAGR-
5y Earnings CAGR-
Gross Margin40.0%
Operating Margin-9322.9%
Net Margin0.0%
ROE-46.4%
Debt / Equity1.85x
Free Cash Flow$-45,931,124
Insider Ownership10.5%
Institutional Ownership33.0%
Short % of Float13.05%
Days to Cover6.4d
1 Week+5.6%
1 Month-
3 Months-
6 Months-
YTD-
1 Year-
3 Years-
5 Years-
vs 50-day SMA-
vs 200-day SMA-
vs 52w High-
vs 52w Low-
Insider Transactions
| Filer | Role | Type | Shares | Price | Value | Date |
|---|---|---|---|---|---|---|
| HAWKINS JEFFREY ALAN | Chief Executive Officer | Sale | 167,424 | $1.00 | $0.17M | 2026-04-21 |
| KEYES JEFFRY R | Chief Financial Officer | Sale | 74,763 | $1.00 | $0.07M | 2026-04-21 |
| HAWKINS JEFFREY ALAN | Chief Executive Officer | Sale | 23,777 | $0.83 | $0.02M | 2026-03-23 |
| KEYES JEFFRY R | Chief Financial Officer | Sale | 8,655 | $0.83 | $0.01M | 2026-03-23 |
| LAPOINTE CHRISTIAN | General Counsel | Sale | 11,959 | $0.83 | $0.01M | 2026-03-23 |
Top Holders
| Holder | Type | % Held | Value | Δ Shares | As of |
|---|---|---|---|---|---|
| Blackrock Inc. | institution | 6.65% | $0.01B | +15.30% | 2025-12-31 |
| Vanguard Group Inc | institution | 4.89% | $0.01B | +10.24% | 2025-12-31 |
| ARK Investment Management, LLC | institution | 3.57% | $0.01B | -7.90% | 2025-12-31 |
| ARK ETF Trust-ARK Genomic Revolution ETF | fund | 3.53% | $0.01B | +3.25% | 2026-04-30 |
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | fund | 2.48% | $0.00B | -0.30% | 2025-12-31 |
| Sumitomo Mitsui Trust Group, Inc. | institution | 2.24% | $0.00B | -6.38% | 2026-03-31 |
| Amova Asset Management Americas Inc | institution | 2.24% | $0.00B | -6.38% | 2026-03-31 |
| iShares Trust-iShares Russell 2000 ETF | fund | 2.12% | $0.00B | +8.01% | 2026-03-31 |
| Geode Capital Management, LLC | institution | 2.09% | $0.00B | +9.80% | 2025-12-31 |
| State Street Corporation | institution | 1.81% | $0.00B | +26.45% | 2025-12-31 |
| Citadel Advisors Llc | institution | 1.36% | $0.00B | +557.44% | 2025-12-31 |
| Susquehanna International Group, LLP | institution | 1.19% | $0.00B | +14.05% | 2025-12-31 |
| Northern Trust Corporation | institution | 1.12% | $0.00B | -4.95% | 2025-12-31 |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | fund | 1.02% | $0.00B | +15.35% | 2025-12-31 |
| Fidelity Salem Street Trust-Fidelity Small Cap Index Fund | fund | 0.79% | $0.00B | +0.69% | 2026-02-28 |
| iShares Trust-iShares Russell 2000 Value ETF | fund | 0.75% | $0.00B | +10.79% | 2026-03-31 |
| iShares Trust-iShares Biotechnology ETF | fund | 0.62% | $0.00B | -4.18% | 2026-03-31 |
| Northern Funds-SMALL CAP VALUE FUND | fund | 0.45% | $0.00B | -6.11% | 2025-12-31 |
| VANGUARD SCOTTSDALE FUNDS-Vanguard Russell 2000 Index Fund | fund | 0.40% | $0.00B | +1.28% | 2026-02-28 |
| Fidelity Concord Street Trust-Fidelity Extended Market Index Fund | fund | 0.26% | $0.00B | -47.16% | 2026-02-28 |
| Ticker | Cap | Score | P/E | Fwd P/E | EV/EBITDA | ROE | Gross | D/E | Div |
|---|---|---|---|---|---|---|---|---|---|
| AVNS | $1.2B | 60 | - | 19.8 | 22.1 | -9.2% | 50% | 17.70 | 0.00% |
| BFLY | $1.2B | - | - | - | - | - | - | - | 0.00% |
| TNDM | $1.2B | - | - | - | - | - | - | - | 0.00% |
| INSP | $1.3B | 56 | 10.9 | 34.6 | - | - | - | - | 0.00% |
| PRCT | $1.4B | 5 | - | - | - | - | - | - | 0.00% |
| ENOV | $1.4B | 100 | - | 6.0 | - | - | - | - | 0.00% |
Peers selected by sector + industry + nearest market cap. Best in column highlighted green, worst red.
Unlock Full Financials
Growth metrics, valuation multiples, and profitability ratios on Starter+.
Recent Alerts
No alerts yet for QSI.
Want deep analysis?
This stock isn't in the ACCE researched universe. Browse 300+ stocks with full thesis, scores, and financial models.
Browse ACCE Indices →Get the ACCE weekly digest
Index returns, picks recap, score movers - every Sunday. No fluff.